The European Medicines Agency has granted orphan drug status to LTI-03, an inhaled therapy being developed for people with ...

Columnist Kylene Henderson is starting the year by focusing on progress and wellness, even if it means only small changes.

New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...

Artificial intelligence has come a long way, writes columnist Sam Kirton, who argues for its role in medicine and in his own care with PF.

Over the holidays, for the first time in a long while, my home was full of voices, laughter, movement, and the comfort of family. I hosted the gathering, something I hadn’t been able to do in years.

If you’re a regular reader of my column, you’ve likely heard me say before that transplant patients commit to a lifetime of medical surveillance. As of Jan. 7, I’ve had 139 medication changes since I ...

Individuals with lingering signs of pulmonary fibrosis (PF) months after recovering from COVID-19 were found to be older and to have significantly lower levels than normal of beneficial gut bacteria, ...

When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in the early days of 2017, it seemed like my world moved in slow motion. Just a few months earlier, as my diagnostic journey began in the ...